chrisvoncsefalvay/vaers-outcomes huggingface dataset:
15 year old received Moderna dose for her 1st covid vaccine. This was per the parent's request. Patient should have received Pfizer vaccine based on her age. We have spoken with her mother and explained she will receive Pfizer to complete the series. No adverse reaction to the vaccine.
Sinus Headache; Condition worsened; A spontaneous report was received from a Consumer concerning a 69 year-old male patient who received Modern's COVID-19 vaccine (mRNA-1273) and experienced sinus headache and condition worsened.  The patient's medical history include regular sinus headaches.  No concomitant medication are reported.   On 08-Feb-2021, patient received the first of two planned doses of mRNA-1273 (lot/batch: 013M20A) in left arm for prophylaxis of COVID-19 infection.  .  On 08-Feb-2021, the patient experienced the event of sinus headache.  No Laboratory details provided.  No treatment medication has been provided.  Action taken with mRNA-1273 in response to the events was not reported.   At the time of this report, the outcome of the events, sinus headache, and condition worsened, was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Fever 102, fast heart rate, muscle pain, pain L elbow, numbness L little and ring fingers.  All symptoms were resolved when she got up Sat. morning 4/2/16.
Patient complained that injection hurt slightly at time of administration. By 2 hours later, having pain radiating down left arm and back. Arm swollen with localized warmth. Hurt so much that didn't sleep for 3 nights. Also had headache. Went to clinic on 3/2/01, Darvoset prescribed. Has improved but still having pain in arm.
pt devel high fever, atrial fibrillation, SOB, congestive heart failure & short term delirium;sx began w/in 12-24hr of vax;tx was hosp;oxygenation via nasal cannula, digoxin & supportive therapy;large local rxn was also noted;
Hospitalization: 5/5/2023 - 5/10/2023 (5 days) Presentation to the ED: Worsening productive cough COVID + date: 5/5/2023 Treatment: Rocephin and doxycycline. IV Decadron Discharge to: HOME.  EL9269 2/8/2021 EN6200 3/2/2021 FF2588 10/1/2021 054A22A 6/4/2022
Tingling in feet and lower calf muscle a few hours after injection. Some calf swelling and light throbbing two days later, continued tingling in feet (pins and needles) now on day 4 after injection and unresolved. Tingling increases after physical activity. Swelling has subsided on day 4. Treated only with rest, compression socks, and keep legs raised when possible, so far. Some swelling of the lymph nodes in groin area.
Severe pain in shoulder down arm, Unable to lift arm,  This has been contiuing now for the eighth day.
Started with slight ringing in my right ear. Became more congested. Had headache. After about a week I noticed tingling sensation on the right side of my face which since has become numbness now. Also had muffled hearing in my right ear. To date I have about 30 percent hearing and it hasn't improved. Very concerned I'll lose all hearing in it. Went to dr was prescribed z pack to clear it up. Didn't work.
Frequent heart palpitations, particularly noticeable during exercise when laying down. Heaviness and pressure in chest and heart. Uncharacteristically out of breath and distressed during exercise and exertion. Exacerbated existing EIVT (Exercise Induced Ventricular Tachycardia). Symptoms persisted for the following four weeks. I did not seek a diagnosis but I believe I experienced a mild form of myocarditis.
Stinging sensation shortly after receiving injection. Next day symptoms evolved to include pruritus encompassing entire body, severe headache, severe arm pain.
By the end of night of vaccine, fevers, chills, body aches and Joint pain and fatigue; The next day - site soreness, body aches, fatigue and headache. The end of the next night (third night) I had joint pain that was continuing but I didn't have any other of the symptoms. I had joint pain for at least over a week  until I sought care. I went to primary care doctor - no testing. She prescribed me ibuprofen. That helped with the pain. I have taken that as needed since that time for joint pain. Next - more recently - starting on July 30th, Urgent Care - I  really bad sore throat, body aches, chills, I had a severe headache and joint pain. Treatment: Penicillin -500mg tablet for 10 days. Have not recovered from this latter health event. Still having my symptoms.
02/12/22 presents to ED for "worsening right-sided facial pain". PMHx of "R sided trigeminal neuralgia s/p medical and neurosurgical interventions" "Dystonia,GERD, Kidney stones, Migraines"
Thursday - injection. Pain upon injection. A couple of hours it was swelling, hot, tender to touch, no appetite, sluggish, achy. Began taking ADVIL. The swelling and redness began to creep down my upper arm. Friday - called the doctor the day after the injection and the nurse said these items are side effects. Saturday - soreness. Redness, hot and swelling was 6 inches below the injection site.  Sunday the redness, hot and swelling was getting better from the injection site to about 3 inches below, but still tender to touch, but below the injection site about 2 inches  the redness, hot and swelling is still a concern. Monday - the injection site to 3 inches below is itchy and still tender, and the lower part is still red, hot, swelling and tender. I've never experienced this type of reaction to an injection. Made me think it could be cellulitis.
Migrating Hives - Extremely itchy, small welts, migrating from arms, to back, to neck.
chills; not feeling well; This is a spontaneous report received from a contactable consumer via Pfizer Sponsored Program COVAX Support. A 72-year-old male patient (husband) received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported), dose 2 via an unspecified route of administration on 12Feb2021 as dose 2, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date in Feb2021, patient experienced chills, not feeling well and wanted to know if he can take Tylenol. The clinical outcome of events was unknown.  Follow-up attempts completed. No further information expected.
tested positive for the COVID19; tested positive for the COVID19; body ache; headache; chills; This is a spontaneous report from a contactable consumer or other non-health care professional (patient). A male patient of an unknown age received bnt162b2 (COMIRNATY, PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Batch no/Lot Number/expiration date: not reported) via unknown route of administration on an unknown date in 2021 as dose 1, single for covid-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that patient was fine until the 4th day of vaccination. On an unknown date in Sep2021, when he woke up and experienced body ache, headache, and chills. Patient also tested positive for the COVID-19. Patient wanted to know if it was common to not feel side effects until the 4th day and if it was from the vaccine, he got COVID-19 infection, also wanted to know how long he should quarantine for COVID-19 infection. On an unknown date in Sep2021, the patient underwent lab tests and procedures which included Sars-Cov2-test results positive for Covid-19. The outcome of the events was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Patient received Tdap, Hep A, MCV vaccines. Approximately 10 minutes later patient stood up, became dizzy, and fell to the floor. He remained awake and alert throughout. He was helped up and sat in a chair. He attempted to stand again approximately 15 later, and again became dizzy and fell to the floor. He was again helped into a chair, and given water to drink. He rested for 20+ minutes, then stood, and walked out without further incident.
pt recv vax 20OCT95 & 2 days later exp flushing & clamminess;sx were reportedly more pronounced & w/fever;pt is under the car of personal MD who indicated that immunization aggravated the pt mitral valve prolapse;
Headache, Myalgia, Fever, lump under left arm axilla the size of a baseball or bigger, not red, not hot, but very painful, also had chills yesterday, fever was at 102F Narrative:  Has appt to see Occ Health provider today to evaluate the lump. Occupational health evaluated the mass, it appears to be fluid filled and may be larger than a baseball, it is substantial, the employee was sent to the ED for further evaluation to rule out infection or other possible diagnosis. Patient will need an ultrasound, CT scan, blood work, etc.
Pt recvd booster dose of MMR 10JUN91 & on 25JUN91 exp numbness in legs & devel an unsteady gait; pt hospitalized & dx w/GBS synd;
Around 6:30pm on 12/29/20, I started experiencing tightness in my chest and at 7 pm experienced a severe asthma attack. I used my asthma rescue inhaler and the tightness in my chest and trouble breathing subsided around 8pm. I also experienced a slight fever of 100.9 and chills for about 45 minutes and could not hold down any food. for the course of the night. As of the next morning, I am still having trouble holding down food and still feeling a slight tightness in my chest.
Initial report received from a healthcare professional on 30 JULY 2013. This is an invalid case as individual patient identifiers and specific adverse reactions were not reported. Several patients whose age, gender, medical history and concomitant medications were not reported, had received a dose of ADACEL (batch number, route, dose and anatomical site of administration were not reported) on an unspecified date. As per reporter; "since they changed back to ADACEL syringes they had a lot of patients with reactions' (type of reaction was not specified). Corrective treatment and laboratory investigations were not reported. Outcome of the event was not reported. Documents held by sender: none
Pt. received vaccination 9/9/16. On 9/11/16 started having flu like symptoms which got worse over time. Went to PCP to get TAMIFLU 10/10/16.
Patient reported having hives from flu shot she received 2 years ago. No other details reported other than patient no longer gets flu shots
On 09/03/02021 around 12:00PM my heart rate went up to 220 per minutes. I called paramedics they gave me 3 shots adenosine. It brought my heart rate down. They took me to the hospital. They did blood test to make sure I wasn't haven't heart attack. They monitored me for 45 minutes to an hour. They released me and they told me to see my cardiologist. After that happened I started to irregular heart beat which continued till this day. I went to 1 and 2 electrophysiologist. I was told that the vaccine triggered birth defects which is called AVNRT. It requires an abrasion. I haven't done the abrasion yet. The irregular heart heart can not be fixed it might had come from adenosine. I have irregular heart beat ongoing. I had a first follow up in the hospital 09/10/2021, Cardiologist. I went to Electrophysiologist on 09/28/2021. Second appointment 11/15/2021 Electrophysiologist.
Patient who received a dose past 30-day use by date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient who received a dose past 30-day use by date) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient who received a dose past 30-day use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient who received a dose past 30-day use by date) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medication was reported. No Treatment information was reported.   This case was linked to MOD-2021-355908 (Patient Link).
warm in arm; delayed red circle about the size of baseball; Initial redness; Swollen arm; minor arm pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (warm in arm), PERIPHERAL SWELLING (Swollen arm), PAIN IN EXTREMITY (minor arm pain), ERYTHEMA (delayed red circle about the size of baseball) and INJECTION SITE ERYTHEMA (Initial redness) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     Concurrent medical conditions included Thyroiditis (Hashimoto Thyroiditis), Migraine headache since 1964, High cholesterol, Vitiligo in 1962, Dairy intolerance (Dairy sensitivity) since 2006 and Osteopenia. Concomitant products included ROSUVASTATIN CALCIUM (CRESTOR) for High cholesterol, CALCIUM, COLECALCIFEROL (CALCIUM PLUS D3) for Osteopenia, LEVOTHYROXINE SODIUM (SYNTHROID) for Thyroiditis, MULTIVITAMIN [VITAMINS NOS], ASCORBIC ACID (VIT C), TOCOPHEROL (VIT E [TOCOPHEROL]), FISH OIL and MACROGOL 3350 (MIRALAX) for an unknown indication.    On 16-Feb-2021 at 10:20 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced PERIPHERAL SWELLING (Swollen arm), PAIN IN EXTREMITY (minor arm pain) and INJECTION SITE ERYTHEMA (Initial redness). On 26-Feb-2021, the patient experienced ERYTHEMA (delayed red circle about the size of baseball). On an unknown date, the patient experienced VACCINATION SITE WARMTH (warm in arm). On 18-Feb-2021, PERIPHERAL SWELLING (Swollen arm), PAIN IN EXTREMITY (minor arm pain) and INJECTION SITE ERYTHEMA (Initial redness) had resolved. At the time of the report, VACCINATION SITE WARMTH (warm in arm) and ERYTHEMA (delayed red circle about the size of baseball) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment was reported.   This case was linked to MOD-2021-265652 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 25-Jul-2021: significant follow up appended on 25-Jul-2021 and added event
Injection site swelling. Sore achy body. Fever.  (Day after initial injection)  Gradually each day the swelling increased in pain and size. Today is 10/15/2020 and the rash area is from just below my shoulder going down the top section of my arm  (1/2 the circumference of my upper arm) ending about 3" up from the bend of the elbow. Needle like pain in the rash area.  Going to walk in clinic to have it looked at and seek advice.
Large bruise-like spots on left arm, right jaw, and left side of chin. Bruise-like spots itch and burn.
They had their first two doses of Gardasil 9 vaccine in October and December 2015. The third dose was dur in April 2016 but this has not yet been administered; This spontaneous information has been received from a consumer, concerning a 13-year-old female patient. The patient's medical history, concurrent conditions, previously drug reactions, allergies and concomitant medications were not provided.  On 19-OCT-2015, the patient was vaccinated with her first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) for prophylaxis (strength, route of administration, anatomical location, lot number and expiration date were not reported). On 22-DEC-2015, the patient received her second dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) for prophylaxis (strength, route of administration, anatomical location, lot number and expiration date were not reported).  On April 2016, the patient was scheduled to receive her third dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) however it was not administered at the time of this report (inappropriate schedule of product administration).  This is one of two reports from the same source.; Sender's Comments:  US-009507513-2001USA006582:
sick; Initial information was received on 24-Nov-2020 regarding an unsolicited valid non-serious case from a consumer (patient) via social media.  This case involves a patient (unknown demographics) who was sick (Illness), while received INFLUENZA VACCINE.  Medical history, past medical treatment, vaccination, family history and concomitant medications were not provided.  On an unknown date, the patient received an INFLUENZA VACCINE (Produced by unknown manufacturer) (lot number, expiry date and other dosing details were not reported)  for prophylactic vaccination.  On an unknown date, patient sick (Illness), (unknown latency), following the administration of INFLUENZA VACCINE. It was reported that the patient was sick for a month and never again to each there own.  Details of laboratory data not reported.  Corrective treatment and outcome were unknown at the time of reporting.  There will be no information available on the batch number for this case.
No adverse effects reported for the patient by the pharmacist.; administration of one dose of MMR II that was reconstituted by an expired STERILE DILUENT; administration of one dose of MMR II that was reconstituted by an expired STERILE DILUENT; This spontaneous report was received from a pharmacist and refers to an approximately 32-year-old patient of unknown gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On 13-NOV-2019, the patient was vaccinated with one dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (recombinant human albumin (rHA))(M-M-R II) 0.5 milliliter (ml) (lot # R036583, expiry date 17-DEC-2020) (route of administration was not reported) for prophylaxis. The vaccine was reconstituted with one dose of expired sterile diluent 0.7 ml (lot# N012922, expiry date 15-OCT-2019) (route of administration was not reported). No adverse effects were reported. Both the measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) and sterile diluent were stored in the correct temperature. The outcome of expired product administered, no adverse event and product preparation issue was unknown.
Chronic severe nausea, digestive upset, dizziness, headaches, fatigue, abrupt loss of 20lbs. Symptoms continuing and chronic since administration of the vaccine.
Received the Shingrix vaccine and got shingles/Suspected vaccination failure; Got shingles; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingrix.     Additional Information: GSK Receipt Date: 06-NOV-2022 Reporter's Comment: This case was reported by a patient via interactive digital media. The patient received the Shingrix vaccine and got shingles as a result.  The reporter wanted to know what compensation was available for his/her follow up care and inconvenience. Additional Supportive Information: This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. The follow up would not possible as no contact details were available.
c/o feeling flushed and slight chest tightness lasted 20 min, no treatment. BP 122/80-HR 80 respiratory 16 easy lungs clear.
Dizziness; headache; tingling around the lips; tingling in all four extremities (upper and lower); left arm and left hand numbness, and fatigue for nine months with tongue twitching for three months.  Continues to have on and off numbness in left arm and left hand.  No treatment prescribed.
2" red patch developed at the vaccination site on arm a week after vaccination.  The red area was warm, itchy, slightly swollen. No treatment given.  Redness resolved after 9-10 days.
Patient admitted with a partial small bowel obstruction, which resolved with conservative management. ED to hospital admission. This visit was within 6 weeks of receiving the COVID vaccine.
Fast heartbeat, faintness approx 10 minutes after administration. 12 hours later chills, fever, muscle and joint pain, especially at injection site.
Reports received covid vaccine on 1/14/2021 - developed left upper arm pain and "cold" feeling. Describes pain as severe and aching. Noticed redness to left distal arm. No fever or chills. No weakness. Grip strong. radial and ulnar pulse 2+. CRT < 3 seconds. Ecchymotic area noted extending from proximal radial region to distal radius. Denies dyspnea. Advised to go to ED - accompanied by on site pharmacist.
24hrs after receiving Tdap, client began to ache, low grade fever, chills, nausea & extreme tiredness.  R arm was slightly red and tender.
I noted that I was unsure as to whether or not I was pregnant and asked the pharmacist if it was safe to go ahead with the second vaccine. She asked if I was trying to conceive and I said, "Yes." She said it was safe to proceed and so I received the shot. By the following day, my period started (6 days early). In my 22.5 years of menstruating, I have never gotten my period early not even by a day or two. Additionally, my period has been very heavy, which is unusual. I have bled through multiple items of clothing, chairs, bed sheets, etc. I was in the process of trying to conceive and believe I was successful in doing so. There were signs of implantation and beginning stages of fertilization. I believe taking this second dose negatively affected that, resulted in an early period, and an early miscarriage. This information was not shared with me prior to the vaccination despite me asking for additional information and putting down "unknown" in response to the question about pregnancy on the form. The pharmacist should've have been more forthcoming about this so that I could've made a more informed decision. Had I known this was a side effect experienced by other women and that it could negatively impact menstruation and conception, I would not have taken this vaccine or any other COVID vaccine. Withholding this information or any other important information takes away the power of the patient to make an informed decision that is in his/her best interest. This was deceptive and unfair.
We had five ped patients that received the PENTACEL. Out of the 5 patients one patient didn't receive the reconstitute ACTHIB.
Patient stated she broke out in a rash on her upper body the day after the vaccine. The rash lasted for 2 days. She did not have this reaction with the first 2 vaccines.
Site: Pain at Injection Site-Mild, Systemic: palpitations-Medium, Systemic: Tachycardia-Medium, Additional Details: per pt she recieved vaccine divided in 4 doses monitored at the clinic, about 1 shot every 30 min.
Patient is not 18 years of age and she received the Moderna vaccine which is intended for ages 18 and up. No signs, symptoms, or side effects.  Vaccine was given on 06.19.21 and father notified us on 06.23.21
Chest cold and head cold symptoms for over 7 days, diaherra on day 7, nausea, and tachacardyia.